Head-to-head
Gala GLP-1 vs Direct Meds
Compared on both medications across the eight dimensions this database records. They differ on 4 of those eight. Gala GLP-1 is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Gala GLP-1 is $179 a month all-in for tirzepatide; Direct Meds is $399. Over twelve months that is $2,148 against $4,788. Value Scores are 91.6 and 45.1 out of 100.
Tirzepatide
Plan pages: Gala GLP-1 plans · Direct Meds plans
At 10 mg/week, Gala GLP-1 is $179 a month all-in and Direct Meds is $399 — $220 apart, or $2,640 across a year. Over twelve months the totals are $2,148 (billed monthly) and $4,788 (billed monthly).
Gala GLP-1 charges a flat $179 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Direct Meds prices tirzepatide by dose: $299 per month at 2.5 mg rising to $399 at 10 mg, a difference of $100 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
| Dose | Gala GLP-1 | Rank | Direct Meds | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $179 | 4/31 | $299 | 17/31 | Gala GLP-1 by $120 |
| 5 mg | $179 | 2/17 | — | — | only Gala GLP-1 publishes |
| 7.5 mg | $179 | 2/17 | — | — | only Gala GLP-1 publishes |
| 10 mg | $179 | 2/27 | $399 | 20/27 | Gala GLP-1 by $220 |
| 12.5 mg | $179 | 2/17 | — | — | only Gala GLP-1 publishes |
| 15 mg | $179 | 2/17 | — | — | only Gala GLP-1 publishes |
Gala GLP-1 is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, Gala GLP-1 sits 3 of 27 on all-in monthly cost and Direct Meds sits 22. There are 18 other programs priced between them. The field median is $339 and the floor is $169, so Gala GLP-1 is below the median and the other is above it. Gala GLP-1 is $10 above the cheapest tirzepatide program on record. Direct Meds is $230 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Gala GLP-1 undercuts it by $270, Direct Meds by $50. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Gala GLP-1 | Direct Meds | Cheaper |
|---|---|---|---|
| Month to month | $179 | $399 | Gala GLP-1 by $220 |
| 3-month term | $199 | — | only Gala GLP-1 publishes this term |
| Settled dose | Gala GLP-1 | Direct Meds | Difference |
|---|---|---|---|
| 2.5 mg | $2,148 | $3,588 | $1,440 apart |
| 5 mg | $2,148 | — | one side unpriced |
| 7.5 mg | $2,148 | — | one side unpriced |
| 10 mg | $2,148 | $4,788 | $2,640 apart |
| 12.5 mg | $2,148 | — | one side unpriced |
| 15 mg | $2,148 | — | one side unpriced |
Gala GLP-1 publishes no rate for 6-month term, 12-month term; Direct Meds publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $2,148 on Gala GLP-1 and $4,688 on Direct Meds — $2,540 apart, and a different gap from the $2,640 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Direct Meds publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 91.6 for Gala GLP-1 and 45.1 for Direct Meds, against a tirzepatide category floor of $169. Gala GLP-1 leads by 46.5 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Gala GLP-1 | 66.1 | 10.5 | 10 | 5 | 91.6 |
| Direct Meds | 29.6 | 10.5 | 0 | 5 | 45.1 |
Semaglutide
Plan pages: Gala GLP-1 plans · Direct Meds plans
At 2.4 mg/week, Gala GLP-1 is $179 a month all-in and Direct Meds is $297 — $118 apart, or $1,416 across a year. Over twelve months the totals are $2,148 (billed monthly) and $3,564 (billed monthly).
Gala GLP-1 charges a flat $179 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Direct Meds prices semaglutide by dose: $249 per month at 0.25 mg rising to $297 at 2.4 mg, a difference of $48 a month between the bottom and top of the ladder. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
Gala GLP-1 is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 75.9 for Gala GLP-1 and 45.9 for Direct Meds, against a semaglutide category floor of $129. Gala GLP-1 leads by 30.0 points, driven mostly by price.
Where the two programs differ
All-in monthly
Gala GLP-1 is cheaper month to month — $179 against $399, a gap of $220 every month, or $2,640 across a year if both rates hold.
Commitment
Gala GLP-1 asks for 3-month plan or standard monthly; confirm exact terms at enrollment; Direct Meds asks for Monthly (no commitment indicated). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
Gala GLP-1 charges one price at every dose; Direct Meds prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Twelve-month cost
Over twelve months the totals are $2,148 for Gala GLP-1 and $4,788 for Direct Meds. Gala GLP-1 is lower by $2,640 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Cancellation terms
Both state the same cancellation terms: Per provider terms.
Evidence status
Both figures carry the same evidence status, reported: sourced from dated third-party reporting; first-party capture pending. Neither is stronger than the other on provenance.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Gala GLP-1 Official site
Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacies (not named publicly), so who actually makes the medication cannot be independently verified; commitment terms are 3-month plan or standard monthly; confirm exact terms at enrollment; cancellation is Per provider terms; availability is stated as All 50 states (per provider claim; confirm at intake).
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, capture 2026-07-14
Watch: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.
Direct Meds Official site
Direct Meds offers compounded GLP-1s in multiple formats — sublingual and injectable — with all-inclusive pricing verified on its own product pages. Semaglutide runs $249–$297/mo and tirzepatide $299–$399/mo depending on format; the lower figures are for sublingual delivery.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly named), so who actually makes the medication cannot be independently verified; commitment terms are Monthly (no commitment indicated); cancellation is Per provider terms; availability is stated as Confirm at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, Direct Meds product pages verified 2026-07-25
Watch: Pricing varies by format and page; product-page 'all-inclusive' rates differ from homepage promo cards. Rank is based on injectable rate as primary. Reported status — RangeYourself verified 2026-07-25 on Direct Meds' own product pages.
What neither record tells you
Gala GLP-1 does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says All 50 states (per provider claim; confirm at intake)
- no specific cancellation or refund terms
Direct Meds does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Confirm at intake
- no specific cancellation or refund terms
Ask Gala GLP-1 and Direct Meds for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. Gala GLP-1, Direct Meds carry a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Gala GLP-1 Official site wins this matchup. If you expect to titrate to the top of the ladder, gala glp-1's flat pricing is worth more than the headline gap suggests.
Both figures should be checked at the provider's own checkout before you pay. Gala GLP-1's tirzepatide price is reported as of 2026-07-14; Direct Meds's is reported as of 2026-07-25.
Questions
Is Gala GLP-1 or Direct Meds cheaper for tirzepatide?
Gala GLP-1 is cheaper on all-in monthly cost at 10 mg/week: $179 against $399, a difference of $220 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Gala GLP-1 versus Direct Meds?
Gala GLP-1 works out to $2,148 across twelve months and Direct Meds to $4,788, on the plan terms each publishes.
Does Gala GLP-1 or Direct Meds raise the price as the dose goes up?
Gala GLP-1: no, it charges one flat rate at every dose. Direct Meds: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Gala GLP-1 and Direct Meds differ?
4 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Gala GLP-1 and Direct Meds names its pharmacy?
Neither. Gala GLP-1 records Partner 503A pharmacies (not named publicly) and Direct Meds records Partner 503A pharmacy (not publicly named). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the Gala GLP-1 and Direct Meds prices?
Gala GLP-1's tirzepatide figure is reported — sourced from dated third-party reporting; first-party capture pending — captured 2026-07-14. Direct Meds's is reported, captured 2026-07-25. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
Gala GLP-1, at $179 a month all-in against $297 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: Gala GLP-1 official site · Direct Meds official site. Compounded tirzepatide and semaglutide are not FDA-approved products.